Latest DRC News
- Details
The University of Alabama at Birmingham Diabetes Research Center (DRC) has named six recipients of the 2026 Pilot and Feasibility Grant Program, which identifies and supports new outstanding and innovative diabetes research projects at UAB.
- Details
The UAB Comprehensive Diabetes Center (UCDC) and Diabetes Research Center (DRC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 86th Scientific Sessions, June 5-8, at the Ernest N. Morial Convention Center in New Orleans.
- Details
Researchers at the University of Alabama at Birmingham have uncovered a potential solution to one of the biggest challenges in modern obesity treatment: rapid weight regain after stopping GLP-1 medications, including semaglutide or tirzepatide.
- Details
As UAB researchers continue to study how these drugs work and what comes next, their findings are helping move the conversation beyond hype, while working toward a clearer understanding of one of the most significant medical breakthroughs of the past decade.
- Details
An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act.
- Details
Jennifer Pollock, Ph.D., professor in the Department of Medicine, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.
- Details
A new tool in understanding and improving nutrition for all now resides at the University of Alabama at Birmingham. The Department of Nutrition Sciences is now home to a brand-new metabolic kitchen and a teaching kitchen, which will significantly enhance the department’s research, education, clinical and community outreach capabilities.
- Details
A new combination drug therapy is showing extraordinary promise in the bout against obesity, helping patients lose an average of 20 percent of their body weight in a major clinical trial.
- Details
Nine UAB faculty members elevated to Distinguished and University professorships
- Details
UAB Comprehensive Diabetes Center (UCDC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 85th Scientific Sessions, June 20-23, at the McCormick Place Convention Center in Chicago.